Source: Annual Congress 2010 - Experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. G. Marangoni, E. R. Parra, A. P. P. Velosa, W. R. Teodoro, N. H. Yoshinari, V. L. Capelozzi (Brazil). Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis. Eur Respir J 2010; 36: Suppl. 54, 1077

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Collagen V nasal tolerance reverts pulmonary immune cells proliferation and interstitium remodeling in experimental scleroderma Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Interaction between vascular collagen V and endothelial apoptosis reinforce the vascular pathway in SSC pathogenesis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension Source: Eur Respir J 2007; 29: 1094-1104 Year: 2007 Adventitial remodeling of experimental pulmonary hypertension induces myofibroblast-produced collagen V in a Th17-pathways-related manner Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2011; 37: 1104-1118 Year: 2011 Increased p130Cas activity induces smooth muscle cell proliferation and migration in idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007